NCT00583908 arm group c55abf3059ed368f0c691d31a1eef451 [clinicaltrials_resource:NCT00583908/arm-group/c55abf3059ed368f0c691d31a1eef451]
senofilcon A [clinicaltrials_resource:d1bec32e24c6ae1152af585257fe15cf]lotrafilcon B toric [clinicaltrials_resource:dbe454cc8b12e1f6c0d4814eaf07ed50]balafilcon A toric [clinicaltrials_resource:e7a6d3b9d9710c1c8dddf8be235185ed]omafilcon A [clinicaltrials_resource:fb8e70cb57ed41c8c16043c2d665b729]clinicaltrials:NCT00583908
arm group [clinicaltrials_vocabulary:arm-group]
NCT00583908 arm group c55abf3059ed368f0c691d31a1eef451 [clinicaltrials_resource:NCT00583908/arm-group/c55abf3059ed368f0c691d31a1eef451]
Bio2RDF identifier
NCT00583908/arm-group/c55abf3059ed368f0c691d31a1eef451
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 5abf3059ed368f0c691d31a1eef451
description [clinicaltrials_vocabulary:description]
One intervention was worn duri ...... con A / period 4: balafilcon A
identifier
clinicaltrials_resource:NCT00583908/arm-group/c55abf3059ed368f0c691d31a1eef451
title
NCT00583908 arm group c55abf3059ed368f0c691d31a1eef451
@en
type
label
NCT00583908 arm group c55abf30 ...... abf3059ed368f0c691d31a1eef451]
@en